Clinical trials
Phase 2 Alzheimer Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 6 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 7 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| Alector Inc. | 2 |
| Boehringer Ingelheim | 2 |
| Cognition Therapeutics | 2 |
| EIP Pharma Inc | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Vivoryon Therapeutics N.V. | 2 |
| AbbVie | 1 |
| Alzheon Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 30 |
| Dementia | 7 |
| Cognitive Dysfunction | 3 |
| Neurodegenerative Diseases | 3 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Mental Disorders | 2 |
| Nervous System Diseases | 2 |
| Dementia, Vascular | 1 |
| Marijuana Abuse | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.